Development and in vitro evaluation of polyurethane microparticles as carrier for bevacizumab: an alternative treatment for retinopathy of prematurity. (2014). International Current Pharmaceutical Journal, 3(6), 275-279. https://doi.org/10.3329/icpj.v3i6.18759